GPhC Inspection Framework Update: What Changed in 2026
The GPhC updated its inspection decision making framework in January, and it has folded two documents that used to sit separately, the Findings Framework and the Practice Note on minor non-compliance, into one. That sounds like tidying up, but if you look at what got added rather than just reorganised, there is more to it than housekeeping.
I spent a good chunk of my career on the other side of an inspection, working through exactly this kind of document to decide whether something was a standard not met, a standard met, an area for improvement, or good practice. Those four categories haven’t changed, but the examples underneath them have, and the examples are where inspectors actually anchor their judgement on the day. A framework update that adds new examples is quietly rewriting what gets flagged, even though the standards themselves stay the same.
The one that will land hardest on some pharmacies is around weight management medicines. Under standard 4.2, the framework now expects the prescriber to independently verify a person’s weight, height and body mass index before supplying, rather than relying on what the patient reports. Given how much weight loss prescribing has grown over the last couple of years, largely online, this is clearly aimed at exactly that growth, and I’d expect it to come up in a lot of inspections this year regardless of whether weight loss is a big part of what a pharmacy does.
Websites get more attention too. Standard 3.1 now spells out that a pharmacy website offering prescribing services has to be clear and transparent about who is actually providing that service, the prescriber’s name, and whether they’re a doctor or a non-medical prescriber. I built a tool last year that runs exactly this kind of check against distance pharmacy websites, because I kept seeing sites where you genuinely couldn’t tell who was behind the prescription.
There’s also a strengthened line on business continuity, standard 1.1, which now specifically calls out disruption involving third party providers such as hub and spoke arrangements across different companies. If your continuity plan only covers your own four walls and doesn’t say anything about what happens if a hub partner goes down, that’s a gap worth closing before a patient complaint surfaces this for you (and others).
None of this is really about ticking a new box. It’s about whether your governance paperwork reflects what actually happens in your pharmacy, and whether you could put your hand on the audit trail if someone asked for it tomorrow. That’s the same conversation I have with pharmacies going through the risk management side of my mock inspection work, and it’s exactly what the Risk Management and Assessment course walks through in more depth if you want to work through it properly rather than just reading about it.
